Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck
- C81.21 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Mixed cellular Hodgkin lymph, nodes of head, face, and neck
- The 2025 edition of ICD-10-CM C81.21 became effective on October 1, 2024.
- This is the American ICD-10-CM version of C81.21 – other international versions of ICD-10 C81.21 may differ.
The following code(s) above C81.21 contain annotation back-references
that may be applicable to C81.21:
- C00-D49 Neoplasms
- C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
- C81 Hodgkin lymphoma
- C81.2 Mixed cellularity Hodgkin lymphoma
Approximate Synonyms
- Hodgkin lymphoma mix cellularity, head lymph node
- Hodgkin mixed cellularity lymphoma, neck ln
- Hodgkin’s disease, mixed cellularity of lymph nodes of head
- Hodgkin’s disease, mixed cellularity of lymph nodes of neck
ICD-10-CM C81.21 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):
- 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
- 012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
- 013 Tracheostomy for face, mouth and neck diagnoses or laryngectomy without cc/mcc
- 820 Lymphoma and leukemia with major o.r. Procedures with mcc
- 821 Lymphoma and leukemia with major o.r. Procedures with cc
- 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
Convert C81.21 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): Revised code
- New description: Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck
- 2016 description: Mixed cellularity classical Hodgkin lymphoma, lymph nodes of head, face, and neck
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change